版本:
中国

BRIEF-Lexicon Pharmaceuticals says Xermelo 250 mg has been included as a recommended treatment option in latest national comprehensive cancer network

June 19 Lexicon Pharmaceuticals Inc

* Lexicon Pharmaceuticals Inc - Xermelo 250 mg has been included as a recommended treatment option in latest national comprehensive cancer network

* Lexicon Pharmaceuticals Inc - Xermelo has also been included in NCCN Drugs & Biologics Compendium Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐